Tumour cells that produce interleukin-15 boost immune responses against cancer
Author Information
Author(s): Hazama S, Noma T, Wang F, Iizuka N, Ogura Y, Yoshimura K, Inoguchi E, Hakozaki M, Hirose K, Suzuki T, Oka M
Primary Institution: Yamaguchi University School of Medicine
Hypothesis
Does interleukin-15 gene transfer into tumour cells enhance the host's anti-tumour response?
Conclusion
IL-15-secreting tumour cells can stimulate both local and systemic T-cell-dependent immunity, suggesting a potential role in cancer therapy.
Supporting Evidence
- IL-15 producing Meth-A cells were completely rejected by the immune system in BALB/c mice.
- The immune response was characterized by a massive infiltration of CD4+ T-cells and neutrophils.
- Meth-A cells without IL-15 grew rapidly, indicating the importance of IL-15 in immune response.
- Rechallenged parental cells were also rejected, showing a lasting immune memory.
- No significant difference was observed in nude mice, suggesting the role of T-cells in the response.
Takeaway
Scientists found that cancer cells that make a special protein called interleukin-15 can help the body's immune system fight cancer better.
Methodology
The study involved gene transfer of IL-15 into tumour cells and observing the immune response in BALB/c and nude mice.
Limitations
The study was conducted in mice, which may not fully represent human responses.
Participant Demographics
BALB/c and nude mice were used in the experiments.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website